The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Equine Influenza Vaccine-Global Market Insights and Sales Trends 2024
Synopsis
Equine influenza (horse flu) is the disease caused by strains of influenza A that are enzootic in horse species. Equine influenza occurs globally, previously caused by two main strains of virus: equine-1 (H7N7) and equine-2 (H3N8). The World Organisation for Animal Health now considers H7N7 strains likely to be extinct since these strains have not been isolated for over 20 years. Predominant international circulating H3N8 strains are Florida sublineage of the American lineage; clade 1 predominates in the Americas and clade 2 in Europe. (Elton and Cullinane, 2013; Paillot, 2014; Slater et al., 2013[4]). The disease has a nearly 100% infection rate in an unvaccinated horse population with no prior exposure to the virus.
The global Equine Influenza Vaccine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Equine Influenza Vaccine in various end use industries. The expanding demands from the Home, Pet Clinic and Others,, are propelling Equine Influenza Vaccine market. Liquid, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Powder segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Equine Influenza Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Equine Influenza Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Equine Influenza Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Equine Influenza Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Equine Influenza Vaccine covered in this report include Zoetis, Merck Animal Health and Boehringer Ingelheim Vetmedica, etc.
The global Equine Influenza Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Zoetis
Merck Animal Health
Boehringer Ingelheim Vetmedica
Global Equine Influenza Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Equine Influenza Vaccine market, Segment by Type:
Liquid
Powder
Global Equine Influenza Vaccine market, by Application
Home
Pet Clinic
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Equine Influenza Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Equine Influenza Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Equine influenza (horse flu) is the disease caused by strains of influenza A that are enzootic in horse species. Equine influenza occurs globally, previously caused by two main strains of virus: equine-1 (H7N7) and equine-2 (H3N8). The World Organisation for Animal Health now considers H7N7 strains likely to be extinct since these strains have not been isolated for over 20 years. Predominant international circulating H3N8 strains are Florida sublineage of the American lineage; clade 1 predominates in the Americas and clade 2 in Europe. (Elton and Cullinane, 2013; Paillot, 2014; Slater et al., 2013[4]). The disease has a nearly 100% infection rate in an unvaccinated horse population with no prior exposure to the virus.
The global Equine Influenza Vaccine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Equine Influenza Vaccine in various end use industries. The expanding demands from the Home, Pet Clinic and Others,, are propelling Equine Influenza Vaccine market. Liquid, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Powder segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Equine Influenza Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Equine Influenza Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Equine Influenza Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Equine Influenza Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Equine Influenza Vaccine covered in this report include Zoetis, Merck Animal Health and Boehringer Ingelheim Vetmedica, etc.
The global Equine Influenza Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Zoetis
Merck Animal Health
Boehringer Ingelheim Vetmedica
Global Equine Influenza Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Equine Influenza Vaccine market, Segment by Type:
Liquid
Powder
Global Equine Influenza Vaccine market, by Application
Home
Pet Clinic
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Equine Influenza Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Equine Influenza Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Equine Influenza Vaccine Market Overview
1.1 Equine Influenza Vaccine Product Overview
1.2 Equine Influenza Vaccine Market Segment by Type
1.2.1 Liquid
1.2.2 Powder
1.3 Global Equine Influenza Vaccine Market Size by Type
1.3.1 Global Equine Influenza Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Equine Influenza Vaccine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Equine Influenza Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Equine Influenza Vaccine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Equine Influenza Vaccine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Equine Influenza Vaccine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Equine Influenza Vaccine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Equine Influenza Vaccine Sales Breakdown by Type (2018-2023)
2 Global Equine Influenza Vaccine Market Competition by Company
2.1 Global Top Players by Equine Influenza Vaccine Sales (2018-2023)
2.2 Global Top Players by Equine Influenza Vaccine Revenue (2018-2023)
2.3 Global Top Players by Equine Influenza Vaccine Price (2018-2023)
2.4 Global Top Manufacturers Equine Influenza Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Equine Influenza Vaccine Market Competitive Situation and Trends
2.5.1 Equine Influenza Vaccine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Equine Influenza Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Equine Influenza Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Equine Influenza Vaccine Market
2.8 Key Manufacturers Equine Influenza Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Equine Influenza Vaccine Status and Outlook by Region
3.1 Global Equine Influenza Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Equine Influenza Vaccine Historic Market Size by Region
3.2.1 Global Equine Influenza Vaccine Sales in Volume by Region (2018-2023)
3.2.2 Global Equine Influenza Vaccine Sales in Value by Region (2018-2023)
3.2.3 Global Equine Influenza Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Equine Influenza Vaccine Forecasted Market Size by Region
3.3.1 Global Equine Influenza Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Equine Influenza Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Equine Influenza Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Equine Influenza Vaccine by Application
4.1 Equine Influenza Vaccine Market Segment by Application
4.1.1 Home
4.1.2 Pet Clinic
4.1.3 Others
4.2 Global Equine Influenza Vaccine Market Size by Application
4.2.1 Global Equine Influenza Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Equine Influenza Vaccine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Equine Influenza Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Equine Influenza Vaccine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Equine Influenza Vaccine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Equine Influenza Vaccine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Equine Influenza Vaccine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Equine Influenza Vaccine Sales Breakdown by Application (2018-2023)
5 North America Equine Influenza Vaccine by Country
5.1 North America Equine Influenza Vaccine Historic Market Size by Country
5.1.1 North America Equine Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Equine Influenza Vaccine Sales in Volume by Country (2018-2023)
5.1.3 North America Equine Influenza Vaccine Sales in Value by Country (2018-2023)
5.2 North America Equine Influenza Vaccine Forecasted Market Size by Country
5.2.1 North America Equine Influenza Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Equine Influenza Vaccine Sales in Value by Country (2024-2029)
6 Europe Equine Influenza Vaccine by Country
6.1 Europe Equine Influenza Vaccine Historic Market Size by Country
6.1.1 Europe Equine Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Equine Influenza Vaccine Sales in Volume by Country (2018-2023)
6.1.3 Europe Equine Influenza Vaccine Sales in Value by Country (2018-2023)
6.2 Europe Equine Influenza Vaccine Forecasted Market Size by Country
6.2.1 Europe Equine Influenza Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Equine Influenza Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Equine Influenza Vaccine by Region
7.1 Asia-Pacific Equine Influenza Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Equine Influenza Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Equine Influenza Vaccine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Equine Influenza Vaccine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Equine Influenza Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Equine Influenza Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Equine Influenza Vaccine Sales in Value by Region (2024-2029)
8 Latin America Equine Influenza Vaccine by Country
8.1 Latin America Equine Influenza Vaccine Historic Market Size by Country
8.1.1 Latin America Equine Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Equine Influenza Vaccine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Equine Influenza Vaccine Sales in Value by Country (2018-2023)
8.2 Latin America Equine Influenza Vaccine Forecasted Market Size by Country
8.2.1 Latin America Equine Influenza Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Equine Influenza Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Equine Influenza Vaccine by Country
9.1 Middle East and Africa Equine Influenza Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Equine Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Equine Influenza Vaccine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Equine Influenza Vaccine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Equine Influenza Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Equine Influenza Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Equine Influenza Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Zoetis
10.1.1 Zoetis Company Information
10.1.2 Zoetis Introduction and Business Overview
10.1.3 Zoetis Equine Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Zoetis Equine Influenza Vaccine Products Offered
10.1.5 Zoetis Recent Development
10.2 Merck Animal Health
10.2.1 Merck Animal Health Company Information
10.2.2 Merck Animal Health Introduction and Business Overview
10.2.3 Merck Animal Health Equine Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck Animal Health Equine Influenza Vaccine Products Offered
10.2.5 Merck Animal Health Recent Development
10.3 Boehringer Ingelheim Vetmedica
10.3.1 Boehringer Ingelheim Vetmedica Company Information
10.3.2 Boehringer Ingelheim Vetmedica Introduction and Business Overview
10.3.3 Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Products Offered
10.3.5 Boehringer Ingelheim Vetmedica Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Equine Influenza Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Equine Influenza Vaccine Industrial Chain Analysis
11.4 Equine Influenza Vaccine Market Dynamics
11.4.1 Equine Influenza Vaccine Industry Trends
11.4.2 Equine Influenza Vaccine Market Drivers
11.4.3 Equine Influenza Vaccine Market Challenges
11.4.4 Equine Influenza Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Equine Influenza Vaccine Distributors
12.3 Equine Influenza Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
